Results 1-6 of 6 (Search time: 0.001 seconds).
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome Patients (Journal article)
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia (Journal article)
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals (Journal article)
Phenotype determinants of the thiglycerides lowering effect of rosuvastatin (Journal article)
LDL cholesterol estimation in patients with the metabolic syndrome (Journal article)
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia (Journal article)